Focused on our patient-centric principles, our portfolio of diagnostic products and technology solutions result in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. We manufacture our own clinically validated, FDA-registered test kits according to ISO 13485 standards and perform all diagnostics in our state-of-the-art, CLIA-certified lab utilizing proprietary diagnostic technologies.
The transition from in-office to at-home breath testing was relatively seamless with CDI. It was very easy to order the testing online, and the results were reliably returned to me electronically. Many of my patients appreciated the ability to complete this testing at home, especially when the pandemic was at its worst.
The implementation of breath testing has been a major improvement in patient care for our practice. Bloating is an extremely common and frustrating complaint from patients that we can now provide an answer for in many cases.
Breath testing has been hugely beneficial for my practice for many years. It allows me to help patients who have seen multiple doctors without finding the cause of their problems, and who continue to struggle with digestive dysfunction.
It can be challenging to diagnose IBS-D and malabsorption in a busy clinical practice. Having an objective marker to diagnose and reassure the patient and provider is a great asset in my practice. It also helps me to manage the condition by using appropriate treatment.
Salem, Mass. – August 11, 2022 – Commonwealth Diagnostics International, Inc. (CDI), an innovative GI health company providing industry-leading diagnostic…
Each month, the CDI team rounds up some of the latest #GIcommunity research, news, and trends, and how they impact…
The second issue of Modern Gastro presented by CDI featuring the latest functional gastrointestinal (GI) trends and insights is now…
